Cancer Epidemiology, Biomarkers & Prevention
| Discipline | Cancer epidemiology |
|---|---|
| Language | English |
| Edited by | Timothy R. Rebbeck |
| Publication details | |
| History | 1991-present |
| Publisher | |
| Frequency | monthly[1] |
| 4.324 (2013) | |
| Standard abbreviations | |
| ISO 4 | Cancer Epidemiol. Biomarkers Prev. |
| Indexing | |
| CODEN | CEBPE4 |
| ISSN | 1055-9965 (print) 1538-7755 (web) |
| OCLC no. | 23441645 |
| Links | |
Cancer Epidemiology, Biomarkers & Prevention is a peer-reviewed medical journal devoted to research in the field of cancer epidemiology. Topics include descriptive, analytical, biochemical, and molecular epidemiology, the use of biomarkers to study the neoplastic and preneoplastic processes in humans, chemoprevention and other types of prevention trials, and the role of behavioral factors in cancer etiology and prevention.
Indexed by ISI Cancer Epidemiology, Biomarkers & Prevention collected an impact factor of 4.324 as reported in the 2013 Journal Citation Reports by Thomson Reuters, ranking it 46 out of 202 journals in the category Oncology [2] and ranking it 12 out of 160 journals in the category Public, environmental & occupational health.[3]
References
- ^ Reuters Master Journal List accessed Dec 03, 2009
- ^ "Journals Ranked by Impact: Oncology". 2013 Journal Citation Reports (Sciences ed.). Thomson Reuters. 2014.
{{cite book}}:|work=ignored (help)CS1 maint: postscript (link) - ^ "Journals Ranked by Impact: Public, environmental & occupational health". 2013 Journal Citation Reports (Sciences ed.). Thomson Reuters. 2014.
{{cite book}}:|work=ignored (help)CS1 maint: postscript (link)